Validation of Finnish Diabetes Risk Score Indonesia Version in Yogyakarta

Diabetes mellitus (DM) has developed as a major public health problem in the world. It is estimated that around 50% of diabetics have not been diagnosed in Indonesia, and only two-thirds of those diagnosed are undergoing treatment. This condition must be prevented. The purpose of this study is to de...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:Borneo Journal of Pharmacy Ročník 4; číslo 1; s. 57 - 67
Hlavní autori: Pertiwi, Putri, Perwitasari, Dyah Aryani, Satibi, Satibi
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya 28.02.2021
Predmet:
ISSN:2621-4814, 2621-4814
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract Diabetes mellitus (DM) has developed as a major public health problem in the world. It is estimated that around 50% of diabetics have not been diagnosed in Indonesia, and only two-thirds of those diagnosed are undergoing treatment. This condition must be prevented. The purpose of this study is to determine the validity and reliability of the Indonesian version of FINDRISC as an instrument for predicting type 2 diabetes mellitus (T2DM). This study was an observational study with a cross-sectional design on 60 research subjects who are indigenous people of Yogyakarta who live in Yogyakarta, which can be proven by Identity Cards by the inclusion and exclusion criteria. Validity is tested by the validity of criteria by type while using the area under the receiver-operating curve (ROC-AUC), while reliability is tested by internal consistency using Cronbach's Alpha (α). The results showed that as many as 14 people, or 23.33% experienced uncontrolled fasting blood sugar and 15 people had a risk score of FINDRISC more than 10. Based on the ROC AUC analysis, the value of 0.935 (95% CI 0.865 1.00) with a cut-off point of 10 with the value of Sn = 85%, Sp = 95%, PPV = 85%, NPV = 95%, +LR = 5.66, and -LR = 0.15. Based on the reliability test, the Cronbach's value of 0.727 is obtained. The FINDRISC questionnaire is categorized as valid and reliable so that it can be a screening tool for understanding.
AbstractList Diabetes mellitus (DM) has developed as a major public health problem in the world. It is estimated that around 50% of diabetics have not been diagnosed in Indonesia, and only two-thirds of those diagnosed are undergoing treatment. This condition must be prevented. The purpose of this study is to determine the validity and reliability of the Indonesian version of FINDRISC as an instrument for predicting type 2 diabetes mellitus (T2DM). This study was an observational study with a cross-sectional design on 60 research subjects who are indigenous people of Yogyakarta who live in Yogyakarta, which can be proven by Identity Cards by the inclusion and exclusion criteria. Validity is tested by the validity of criteria by type while using the area under the receiver-operating curve (ROC-AUC), while reliability is tested by internal consistency using Cronbach's Alpha (α). The results showed that as many as 14 people, or 23.33% experienced uncontrolled fasting blood sugar and 15 people had a risk score of FINDRISC more than 10. Based on the ROC AUC analysis, the value of 0.935 (95% CI 0.865 1.00) with a cut-off point of 10 with the value of Sn = 85%, Sp = 95%, PPV = 85%, NPV = 95%, +LR = 5.66, and -LR = 0.15. Based on the reliability test, the Cronbach's value of 0.727 is obtained. The FINDRISC questionnaire is categorized as valid and reliable so that it can be a screening tool for understanding.
Author Perwitasari, Dyah Aryani
Pertiwi, Putri
Satibi, Satibi
Author_xml – sequence: 1
  givenname: Putri
  orcidid: 0000-0003-3906-7811
  surname: Pertiwi
  fullname: Pertiwi, Putri
  organization: Universitas Ahmad Dahlan
– sequence: 2
  givenname: Dyah Aryani
  orcidid: 0000-0002-2638-6664
  surname: Perwitasari
  fullname: Perwitasari, Dyah Aryani
  organization: Universitas Ahmad Dahlan
– sequence: 3
  givenname: Satibi
  orcidid: 0000-0002-5894-9425
  surname: Satibi
  fullname: Satibi, Satibi
  organization: Universitas Gadjah Mada
BookMark eNpNkE1LAzEQhoNUsNaeveYPtM3X7maPUq0uFAQ_Cp7CbDJb09ZNSYrQf-9uK-JphoH3mZfnmgza0CIht5xNpWRazepN2E-_ledTnhXZBRmKXPCJ0lwN_u1XZJzShjEmdKFYwYekWsHOOzj40NLQ0IVvW58-6b2HGg-Y6ItPW_pqQ0Rata57mjzQFcbUB3xLP8L6CFuIB7ghlw3sEo5_54i8Lx7e5k-T5fNjNb9bTixXRTaRjbbSInBmXVPkiAoay1FpKTljpXAcRW616NoxYR0IrnWZ64zVhSyEFXJEqjPXBdiYffRfEI8mgDenQ4hr09XxdoemVFxobFhZykyBkHUmwaGSuc0QwfGONTuzbAwpRWz-eJyZk1jTizW9WNOLlT9kHm2Q
Cites_doi 10.1136/bmjopen-2014-005497
10.1186/1741-7015-11-45
10.1111/dom.12949
10.1007/s11883-003-0040-z
10.1016/j.diabres.2010.12.020
10.1371/journal.pone.0097865
10.1136/bmjopen-2016-013569
10.20473/amnt.v1i2.6229
10.2337/dc05-2366
10.2337/cd18-0105
10.1016/j.pcd.2018.07.015
10.20473/jbe.v2i1.2014.48-58
10.7150/ijms.10001
10.36086/jpp.v13i2.235
10.1016/j.diabres.2016.08.010
10.1186/s12889-015-2298-9
10.2147/DMSO.S67400
10.25133/jpssv27n1.003
10.1111/j.1651-2227.2006.00180.x
10.1038/sj.jhh.1002159
10.17977/um044v4i1p56-62
10.31101/jkk.550
10.1155/2014/261672
10.1002/9781118548387
10.25077/njk.13.1.10-14.2017
10.3132/dvdr.2005.011
10.1016/j.diabres.2019.02.017
10.18203/2394-6040.ijcmph20174819
ContentType Journal Article
DBID AAYXX
CITATION
DOA
DOI 10.33084/bjop.v4i1.1575
DatabaseName CrossRef
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
DatabaseTitleList
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 2621-4814
EndPage 67
ExternalDocumentID oai_doaj_org_article_94128ef099354a23b53ade436c5eead1
10_33084_bjop_v4i1_1575
GroupedDBID AAYXX
ALMA_UNASSIGNED_HOLDINGS
CITATION
GROUPED_DOAJ
M~E
OK1
ID FETCH-LOGICAL-c1475-3f8c3cea10cdf76ee4afc1e483310092d1e26c8207102cda218896850b7372c23
IEDL.DBID DOA
ISSN 2621-4814
IngestDate Fri Oct 03 12:44:16 EDT 2025
Sat Nov 29 03:53:55 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License http://creativecommons.org/licenses/by-sa/4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c1475-3f8c3cea10cdf76ee4afc1e483310092d1e26c8207102cda218896850b7372c23
ORCID 0000-0002-5894-9425
0000-0002-2638-6664
0000-0003-3906-7811
OpenAccessLink https://doaj.org/article/94128ef099354a23b53ade436c5eead1
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_94128ef099354a23b53ade436c5eead1
crossref_primary_10_33084_bjop_v4i1_1575
PublicationCentury 2000
PublicationDate 2021-2-28
PublicationDateYYYYMMDD 2021-02-28
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-2-28
  day: 28
PublicationDecade 2020
PublicationTitle Borneo Journal of Pharmacy
PublicationYear 2021
Publisher Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
Publisher_xml – name: Institute for Researches and Community Services Universitas Muhammadiyah Palangkaraya
References ref13
ref12
ref15
ref14
ref31
ref30
ref11
ref33
ref10
ref32
ref0
ref2
ref1
ref17
ref16
ref19
ref18
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref8
ref7
ref9
ref4
ref3
ref6
ref5
References_xml – ident: ref24
  doi: 10.1136/bmjopen-2014-005497
– ident: ref4
  doi: 10.1186/1741-7015-11-45
– ident: ref10
  doi: 10.1111/dom.12949
– ident: ref25
  doi: 10.1007/s11883-003-0040-z
– ident: ref6
  doi: 10.1016/j.diabres.2010.12.020
– ident: ref7
  doi: 10.1371/journal.pone.0097865
– ident: ref19
  doi: 10.1136/bmjopen-2016-013569
– ident: ref23
  doi: 10.20473/amnt.v1i2.6229
– ident: ref26
  doi: 10.2337/dc05-2366
– ident: ref32
– ident: ref16
  doi: 10.2337/cd18-0105
– ident: ref31
  doi: 10.1016/j.pcd.2018.07.015
– ident: ref13
– ident: ref22
  doi: 10.20473/jbe.v2i1.2014.48-58
– ident: ref3
  doi: 10.7150/ijms.10001
– ident: ref2
– ident: ref15
  doi: 10.36086/jpp.v13i2.235
– ident: ref9
  doi: 10.1016/j.diabres.2016.08.010
– ident: ref5
  doi: 10.1186/s12889-015-2298-9
– ident: ref20
  doi: 10.2147/DMSO.S67400
– ident: ref1
  doi: 10.25133/jpssv27n1.003
– ident: ref33
  doi: 10.1111/j.1651-2227.2006.00180.x
– ident: ref27
  doi: 10.1038/sj.jhh.1002159
– ident: ref28
  doi: 10.17977/um044v4i1p56-62
– ident: ref29
  doi: 10.31101/jkk.550
– ident: ref17
  doi: 10.1155/2014/261672
– ident: ref11
  doi: 10.1002/9781118548387
– ident: ref18
– ident: ref21
  doi: 10.25077/njk.13.1.10-14.2017
– ident: ref0
– ident: ref14
  doi: 10.3132/dvdr.2005.011
– ident: ref8
  doi: 10.1016/j.diabres.2019.02.017
– ident: ref12
– ident: ref30
  doi: 10.18203/2394-6040.ijcmph20174819
SSID ssj0002874071
Score 2.1354313
Snippet Diabetes mellitus (DM) has developed as a major public health problem in the world. It is estimated that around 50% of diabetics have not been diagnosed in...
SourceID doaj
crossref
SourceType Open Website
Index Database
StartPage 57
SubjectTerms Diabetes Mellitus
FINDRISC
Reliability
Validity
Title Validation of Finnish Diabetes Risk Score Indonesia Version in Yogyakarta
URI https://doaj.org/article/94128ef099354a23b53ade436c5eead1
Volume 4
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2621-4814
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002874071
  issn: 2621-4814
  databaseCode: DOA
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2621-4814
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0002874071
  issn: 2621-4814
  databaseCode: M~E
  dateStart: 20180101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS8NAEF2kePAifmL9Yg9SPDRtkt0km6NKiz1Yilapp7CfmBbS0tRCL_52Z5Noc_PiJYcQJuHNkpm3zL6H0E1ktCSCM4fETDgUKqQjtAkdqjzFOCHapaowm4iGQzaZxKOa1ZedCSvlgUvgujGFP6g20MiQgHKfiIBwpSkJZaABhYL4uFFcI1PTYssoskyl1PIBys5oV0zni86apl7HC-xUYa0M1dT6i7LSP0D7VT-I78rvOEQ7OjtCrVEpKL1p4_H2fFTexi082kpNb47R4A3a6NIVCc8N7qdZluYfuBpzyfFzms_wi1WqxANr26HzlONqiwynGX6HKHwGIPAT9NrvjR8encocwZEejQKHGCaJ1NxzpTJRqDXlRnqaMmK37GNfedoPJdR320JIxaGUszhkgSusMY30ySlqZPDeM4QVkC4iY-EHXFBpIq5JZFgooTuKIQxtotsfrJJFqYGRAHcoYE0srImFNbGwNtG9xfL3MSteXdyAlCZVSpO_Unr-H0Eu0J5vx0-K0-eXqLFafuortCvXqzRfXherBa5PX71v7e_G9A
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validation+of+Finnish+Diabetes+Risk+Score+Indonesia+Version+in+Yogyakarta&rft.jtitle=Borneo+Journal+of+Pharmacy&rft.au=Pertiwi%2C+Putri&rft.au=Perwitasari%2C+Dyah+Aryani&rft.au=Satibi%2C+Satibi&rft.date=2021-02-28&rft.issn=2621-4814&rft.eissn=2621-4814&rft.volume=4&rft.issue=1&rft.spage=57&rft.epage=67&rft_id=info:doi/10.33084%2Fbjop.v4i1.1575&rft.externalDBID=n%2Fa&rft.externalDocID=10_33084_bjop_v4i1_1575
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2621-4814&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2621-4814&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2621-4814&client=summon